Medicenna Therapeutics Corp is making waves on the TSX with a notable uptick in stock price.
Medicenna Therapeutics Corp (MDNA.TO) is experiencing a positive performance in today's trading session, rising by 2.86% to a closing price of CA$0.36. This increase comes amid recent developments that may be boosting investor optimism.
Investor takeaway: Investors should consider the implications of Medicenna's recent stock performance and its strategic moves in the biotech sector.
Advertisement
Earn cash back with a smarter spending account
Open a KOHO account and start earning on everyday purchases — no annual fee on the base plan.
Medicenna Therapeutics Corp
MDNA.TO
MDNA.TO
Medicenna Therapeutics Corp
WealthAwesomeMarket cap
$33.23M
52W high
$1.97
52W low
$0.34
1W change
+2.86%
Beta
1.89
Analyst Price Targets
Based on analyst covering MDNA
Wall Street analysts forecast MDNA stock price to rise 788.9% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$3.20
+788.9% Upside
Current Price
C$0.36
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MDNA's historical volatility
30-Day Vol
34.7%
Annualized
90-Day Vol
67.9%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.30
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.34 | C$0.30 – C$0.38 |
| 60 trading days | C$0.32 | C$0.27 – C$0.38 |
| 90 trading days | C$0.30 | C$0.24 – C$0.37 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Medicenna's stock rises 2.86% today
With a market cap of CA$33,228,074, Medicenna's stock performance reflects investor confidence amid ongoing developments.
Bull case
The rise in Medicenna's stock likely stems from the company's strategic initiatives, such as its recent public offering and positive clinical data presentations. These moves can enhance its position in the market and attract more investors.
Bear case
Despite today's gains, investors should stay cautious. The biotech sector can be volatile, and without significant news, stock performance might fluctuate.
Advertisement
Recent Developments Boosting Investor Confidence
Medicenna's stock price increase is likely influenced by its recent announcements, including finalizing terms for a public offering. This step aims to strengthen its financial position and support ongoing research and development efforts. Investors may see this as a proactive approach to future growth.
Market Sentiment and Future Outlook
The positive movement in Medicenna's stock today suggests favorable market sentiment towards the company. However, investors should remain vigilant, as the biotech sector is known for its volatility. Keeping an eye on the company's developments, including clinical trial results and financial updates, will be essential for assessing future performance.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
